Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
Year-over-year SG&A expense growth
Percentile
P36
Within normal range
vs 5Y Ago
-8.9x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -5.88% |
| 2024 | 23.48% |
| 2023 | 43.57% |
| 2022 | -10.19% |
| 2021 | 3.95% |
| 2020 | 0.66% |
| 2019 | 38.79% |
| 2018 | -24.87% |
| 2017 | -9.78% |
| 2016 | 31.02% |